There can be no guarantee that Exelon Patch will achieve any particular levels of revenue within the foreseeable future. get hold of, Management's expectations regarding Exelon Patch could be affected by, amongst other things, immediate clinical trial results, Including out-of-the-ordinary new clinical data and amazing additional analysis of existing clinical data; amazing regulatory actions or delays or government regulation generally; you can actually ability to obtain or maintain patent or other proprietary intellectual property protection; comparison in general; governance, Industry and community pricing pressures; Unexpected manufacturers issues; The impact that the foregoing factors could have on the values attributed to the Novartis Group's properties and investments as recorded in the Group's consolidated balance sheet, And other risks and factors regarded in Novartis AG's current Form 20 F on file with the US Securities and Exchange Commission. Should one or more of these risks or questions materialize, Or should underlying assumptions prove incorrect, Actual results may vary materially from those presumed, thought, judged or }